Singapore, Oct. 29 -- Jiahui International Hospital has launched Jiahui International Cell Therapy Centre (JICC), building on landmark CAR-T cases and multidisciplinary expertise to serve patients from China and abroad.

JICC has established a track record of pioneering CAR-T treatments and encouraging long-term patient outcomes. In September 2023, JICC treated China's first international patient to receive axicabtagene ciloleucel (Axi-Cel) CAR-T therapy, a Singaporean woman with primary mediastinal large B-cell lymphoma, who remains relapse-free more than three years after treatment.

Building on this milestone, JICC has provided CAR-T treatment to patients from Singapore, Hong Kong SAR, Russia, Hungary, New Zealand, India, Pakistan, the...